Stocktwits on MSN
SMMT stock surges overnight: Cancer drug survival win raises the bar as PFE, BMY, MRK chase Keytruda's successor
New ASCO data boosted the case for Ivonescimab as a potential challenger to Merck's blockbuster cancer drug Keytruda. ・Phase ...
24/7 Wall St. on MSN
Why Pfizer’s current price may be too cheap to ignore
Quick Read Pfizer (PFE) trades at $26.18 with a 24/7 Wall St. price target of $32.92, implying 25.76% upside, driven by ...
Jefferies analyst Akash Tewari maintained a Buy rating on Pfizer today and set a price target of $35.00. Claim 55% Off TipRanks. Unlock trusted, data-backed investing tools with T ...
Pfizer Inc. (NYSE:PFE) is one of the best medical stocks to invest in according to billionaires. Pfizer Inc. (NYSE:PFE) ...
We recently compiled a list of the 11 Most Undervalued Pharma Stocks to Invest In. Pfizer Inc. (NYSE:PFE) is one of the most ...
Often, investors and Wall Street analysts focus on the short term and don't give enough thought to the long term.
Pfizer’s biggest competitors in the global pharmaceutical industry are Johnson & Johnson, Roche, Eli Lilly, AbbVie, Novo ...
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...
Pfizer Inc. (NYSE:PFE) is one of the Most Undervalued US Stocks According to Hedge Funds. On May 13, Pfizer Inc.
With an annual dividend yield of 6.37%, Pfizer Inc. (NYSE:PFE) is included among the 10 Best Fortune 500 Dividend Stocks to Invest in Right Now. Pfizer Inc. (NYSE:PFE) discovers, develops, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results